Alzheimer’s Group Pushes Medicare Coverage of Leqembi

Published on March 16, 2023

The Alzheimer’s Association is leading a campaign with 1,000 individuals who have been diagnosed with or are caring for someone with Alzheimer’s disease. Their goal? To meet with every member of Congress and advocate for Medicare coverage of Leqembi, a promising new class of drugs. This effort involves 535 congressional meetings across the United States, where passionate advocates will emphasize the urgent need for early access to this medication. With the potential to slow down the progression of Alzheimer’s, Leqembi could provide hope for millions of patients and their loved ones. The Alzheimer’s Association believes that Medicare coverage of Leqembi is crucial in addressing the growing public health crisis posed by this devastating disease. By rallying together and encouraging policymakers to take action, these determined advocates are making their voices heard and pushing for change. For more information on this important campaign and the groundbreaking research behind Leqembi, be sure to explore the underlying article!

The Alzheimer’s Association has deployed 1,000 people diagnosed with, or caring for someone with the disease, to meet with all 535 members of Congress across the United States and urge them to press Medicare for early access to a new class of drugs, beginning with…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>